PFIZER INC (1PFE.MI) Stock Price, Forecast & Analysis
Europe - BIT:1PFE - US7170811035 - Common Stock
1PFE.MI Key Statistics, Chart & Performance
The current stock price of 1PFE.MI is 21.3 EUR. In the past month the price increased by 2.04%. In the past year, price decreased by -19.36%.
1PFE.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1LLY.MI | ELI LILLY & CO | 39.04 | 703.22B | ||
| LLY.DE | ELI LILLY & CO | 39.03 | 703.03B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.58 | 440.12B | ||
| JNJ.DE | JOHNSON & JOHNSON | 18.19 | 393.33B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 17.74 | 384.13B | ||
| 1ROG.MI | ROCHE HOLDING AG-GENUSSCHEIN | 13.98 | 239.54B | ||
| RHO.DE | ROCHE HOLDING AG-BR | 13.86 | 237.60B | ||
| SNW.DE | SANOFI | 14.26 | 213.75B | ||
| SAN.PA | SANOFI | 11.53 | 213.49B | ||
| 1SAN.MI | SANOFI | 11.48 | 212.63B | ||
| 1NOVN.MI | NOVARTIS AG-REG | 13.84 | 207.14B | ||
| NOT.DE | NOVARTIS AG-REG | 14.16 | 207.52B |
Related stock screener links
About 1PFE.MI
Company Profile
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 81,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Company Info
PFIZER INC
66 Hudson Boulevard East
New York City NEW YORK US
Employees: 81000
Phone: 12127332323
PFIZER INC / 1PFE.MI FAQ
What does PFIZER INC do?
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 81,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
What is the current price of 1PFE stock?
The current stock price of 1PFE.MI is 21.3 EUR. The price increased by 0.59% in the last trading session.
Does 1PFE stock pay dividends?
PFIZER INC (1PFE.MI) has a dividend yield of 7.01%. The yearly dividend amount is currently 1.46.
What is the ChartMill technical and fundamental rating of 1PFE stock?
1PFE.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Should I buy 1PFE stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1PFE.MI.
How many employees does PFIZER INC have?
PFIZER INC (1PFE.MI) currently has 81000 employees.
What is the market capitalization of 1PFE stock?
PFIZER INC (1PFE.MI) has a market capitalization of 121.10B EUR. This makes 1PFE.MI a Large Cap stock.
1PFE.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1PFE.MI. When comparing the yearly performance of all stocks, 1PFE.MI is a bad performer in the overall market: 79.5% of all stocks are doing better.
1PFE.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1PFE.MI. While 1PFE.MI is still in line with the averages on profitability rating, there are concerns on its financial health.
1PFE.MI Financial Highlights
Over the last trailing twelve months 1PFE.MI reported a non-GAAP Earnings per Share(EPS) of 2.93. The EPS increased by 151.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.84% | ||
| ROA | 5.22% | ||
| ROE | 12.12% | ||
| Debt/Equity | 0.65 |
1PFE.MI Forecast & Estimates
30 analysts have analysed 1PFE.MI and the average price target is 25.46 EUR. This implies a price increase of 19.52% is expected in the next year compared to the current price of 21.3.
For the next year, analysts expect an EPS growth of -0.3% and a revenue growth -0.06% for 1PFE.MI